A detailed history of Wolff Wiese Magana LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 130 shares of NTLA stock, worth $1,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130
Previous 130 -0.0%
Holding current value
$1,566
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$23.16 - $32.34 $694 - $970
-30 Reduced 18.75%
130 $3,000
Q3 2023

Oct 30, 2023

SELL
$31.62 - $45.78 $3,162 - $4,578
-100 Reduced 38.46%
160 $5,000
Q1 2023

Apr 18, 2023

SELL
$33.3 - $44.82 $2,331 - $3,137
-70 Reduced 21.21%
260 $9,000
Q4 2022

Feb 08, 2023

SELL
$33.21 - $62.69 $1,826 - $3,447
-55 Reduced 14.29%
330 $11,000
Q2 2022

Jul 15, 2022

SELL
$38.49 - $76.21 $307 - $609
-8 Reduced 2.04%
385 $20,000
Q1 2022

May 09, 2022

SELL
$58.27 - $118.99 $57,862 - $118,157
-993 Reduced 71.65%
393 $29,000
Q4 2021

Jan 18, 2022

SELL
$100.76 - $138.36 $7,859 - $10,792
-78 Reduced 5.33%
1,386 $164,000
Q3 2021

Oct 15, 2021

BUY
$132.37 - $176.78 $34,283 - $45,786
259 Added 21.49%
1,464 $196,000
Q2 2021

Jul 15, 2021

BUY
$60.88 - $161.91 $73,360 - $195,101
1,205 New
1,205 $195,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $916M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.